Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Nuclear respiratory factor-1 (NRF1) was originally found in the cytochrome C promoter. As a regulatory factor, it regulates cellular energy metabolism and transcription and replication of mitochondrial mtDNA. Besides, several studies have shown that NRF1 plays an important role in maintaining mitochondrial homeostasis in cases of heart failure, cardiomyopathy, and other cardiac cell dysfunction.
Figure 1. The mitochondrial bi-directional circuit. NRF1 here is nuclear respiratory factor 1.(Zolotukhin, P. V., et al. 2016)
NRF1 belongs to the nuclear respiratory factor family. NRF1 is an important factor for regulating cell energy metabolism, which can not only regulate the expression of respiratory chain enzyme complex subunits, but also regulate the expression of mitochondrial inner and outer membrane transporter receptor subunits, which plays an important role in regulating the process of cellular mitochondrial oxidation productivity. In addition, it acts as an important nuclear-encoded transcriptional regulator that affects the transcription and replication of mtDNA. Moreover, NRF1 can mediate the coordination between the nuclear and mitochondrial genomes, fight cellular oxidative stress and participate in the biosynthesis of heme. In short, NRF1 can maintain the normal function of mitochondria in various ways. NRF1 is the link between the nuclear genome and the mitochondrial genome, and plays an important role in mitochondrial biosynthesis and respiration. In addition to regulating respiratory function, it also has significance for cell growth, chromosome maintenance, maintaining the excitability of neurons, and enhancing the anti-apoptosis of neurons.
Cardiomyocytes, as high-energy-consuming cells of the body, require a large amount of energy to supply their huge energy requirements, and mitochondria are places where energy is generated. Studies in neonatal cardiomyocytes found that in order to adapt to an oxygen-rich environment, the mitochondria in the cardiomyocytes changed rapidly, and the number of mitochondria and the complexity of the mitochondrial inner membrane increased. Correspondingly, the expression of NRF1 increased sharply and the expression of HIF decreased. Under hypoxic conditions, overexpression of NRF1 gene is beneficial to cell survival. In addition, the NRF1 gene can improve the hypoxic state of the cell, which may be by increasing cell viability, reducing the level of mitochondrial depolarization, increasing the expression level of anti-apoptotic genes and inhibiting the expression level of pro-apoptotic genes, thereby reducing apoptosis rate. In addition, in vitro drugs stimulate cardiomyocytes, promote up-regulation of NRF1 expression, and increase the expression of mitochondrial oxidative phosphorylated protein. The above research speculates that drugs can increase the expression of NRF1 in heart failure cells through stimulation or transcription, causing the expression of mitochondrial DNA and related proteins to increase. This can maintain the functional stability of myocardial cells, slow down the remodeling of myocardial structure, and extend the survival time of the body.
At present, a large number of studies have shown that mitochondria play a key role in the etiology of familial and sporadic Parkinson's disease (PD), and NRF1 is also an important factor in mitochondrial biosynthesis and function regulation. In MPTP-modeled Parkinson's disease model mice, the expression of NRF1 and TFAM was reduced in the substantia nigra and striatum, and there was no significant change in the cerebellum and cerebral cortex. In SH-SY5 Y Parkinson's cell model, by expressing NRF1 or TFAM can obviously restore MPP+ damage to mitochondria and dopaminergic neurons. Its mechanisms include: increasing mitochondrial complex I activity, restoring mitochondrial membrane potential, increasing ATP levels, reducing ROS production, and increasing the expression of tyrosine hydroxylase (TH).
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.